• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ICB-1 基因抑制卵巢癌细胞系的生长。

icb-1 Gene counteracts growth of ovarian cancer cell lines.

机构信息

Department of Obstetrics and Gynecology, University Medical Center Regensburg, Regensburg, Germany.

出版信息

Cancer Lett. 2013 Jul 28;335(2):441-6. doi: 10.1016/j.canlet.2013.02.049. Epub 2013 Mar 6.

DOI:10.1016/j.canlet.2013.02.049
PMID:23474491
Abstract

Human gene icb-1 has been originally identified to be involved in differentiation processes of cancer cells. To examine the function of icb-1 in ovarian cancer, we knocked down its expression in three ovarian cancer cell lines and performed microarray-based gene expression profiling with subsequent gene network modeling. Loss of icb-1 expression accelerated proliferation of SK-OV-3, OVCAR-3 and OAW-42 cells and led to upregulation of ovarian cancer biomarkers like KLK10 and CLDN16. Most of the upregulated genes were part of oncogenic pathways regulated by ERα or TNF. Our data suggest that icb-1 gene inhibits growth and progression of ovarian cancer cells.

摘要

人类基因 icb-1 最初被鉴定为参与癌细胞的分化过程。为了研究 icb-1 在卵巢癌中的功能,我们敲低了三种卵巢癌细胞系中的 icb-1 表达,并进行了基于微阵列的基因表达谱分析和随后的基因网络建模。icb-1 表达的缺失加速了 SK-OV-3、OVCAR-3 和 OAW-42 细胞的增殖,并导致卵巢癌生物标志物如 KLK10 和 CLDN16 的上调。大多数上调的基因是受 ERα 或 TNF 调节的致癌途径的一部分。我们的数据表明,icb-1 基因抑制卵巢癌细胞的生长和进展。

相似文献

1
icb-1 Gene counteracts growth of ovarian cancer cell lines.ICB-1 基因抑制卵巢癌细胞系的生长。
Cancer Lett. 2013 Jul 28;335(2):441-6. doi: 10.1016/j.canlet.2013.02.049. Epub 2013 Mar 6.
2
Expression of differentiation-associated gene icb-1 is estrogen-responsive in ovarian and breast cancer cell lines.分化相关基因icb-1在卵巢癌和乳腺癌细胞系中表达受雌激素调控。
J Steroid Biochem Mol Biol. 2008 Mar;109(1-2):16-21. doi: 10.1016/j.jsbmb.2007.12.007. Epub 2007 Dec 7.
3
Knockdown of ICB-1 gene enhanced estrogen responsiveness of ovarian and breast cancer cells.ICB-1 基因敲低增强了卵巢癌细胞和乳腺癌细胞对雌激素的反应性。
Endocr Relat Cancer. 2010 Feb 18;17(1):147-57. doi: 10.1677/ERC-09-0095. Print 2010 Mar.
4
Expression of icb-1 gene is interferon-gamma inducible in breast and ovarian cancer cell lines and affects the IFN gamma-response of SK-OV-3 ovarian cancer cells.icb - 1基因在乳腺癌和卵巢癌细胞系中可被γ干扰素诱导表达,并影响SK - OV - 3卵巢癌细胞的γ干扰素反应。
Cytokine. 2005 Nov 3;32(3-4):137-42. doi: 10.1016/j.cyto.2005.08.008. Epub 2005 Oct 10.
5
Silencing of the icb-1 gene inhibits the induction of differentiation-associated genes by vitamin D3 and all-trans retinoic acid in gynecological cancer cells.ICB-1 基因沉默抑制维生素 D3 和全反式维甲酸诱导妇科癌细胞分化相关基因的表达。
Int J Mol Med. 2011 Jul;28(1):121-7. doi: 10.3892/ijmm.2011.663. Epub 2011 Mar 31.
6
Differential induction of LRP16 by liganded and unliganded estrogen receptor alpha in SKOV3 ovarian carcinoma cells.在SKOV3卵巢癌细胞中,配体结合型和非配体结合型雌激素受体α对LRP16的差异诱导作用。
J Endocrinol. 2009 Jul;202(1):167-77. doi: 10.1677/JOE-09-0054. Epub 2009 Apr 29.
7
Identification and characterization of novel spliced variants of PRMT2 in breast carcinoma.鉴定和分析乳腺癌中 PRMT2 的新型剪接变体。
FEBS J. 2012 Jan;279(2):316-35. doi: 10.1111/j.1742-4658.2011.08426.x. Epub 2011 Dec 9.
8
Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cells.雌激素受体β激动剂对卵巢癌细胞增殖和基因表达的影响。
BMC Cancer. 2017 May 8;17(1):319. doi: 10.1186/s12885-017-3246-0.
9
Network analysis of icb-1 gene function in human breast cancer cells.人乳腺癌细胞中 icb-1 基因功能的网络分析。
J Cell Biochem. 2012 Sep;113(9):2979-88. doi: 10.1002/jcb.24175.
10
Resveratrol regulates the cell viability promoted by 17β-estradiol or bisphenol A via down-regulation of the cross-talk between estrogen receptor α and insulin growth factor-1 receptor in BG-1 ovarian cancer cells.白藜芦醇通过下调 BG-1 卵巢癌细胞中雌激素受体 α 和胰岛素样生长因子-1 受体之间的串扰,调节 17β-雌二醇或双酚 A 促进的细胞活力。
Food Chem Toxicol. 2013 Sep;59:373-9. doi: 10.1016/j.fct.2013.06.029. Epub 2013 Jun 27.

引用本文的文献

1
Stemness-Relevant Gene Signature for Chemotherapeutic Response and Prognosis Prediction in Ovarian Cancer.用于预测卵巢癌化疗反应和预后的干性相关基因特征
Stem Cells Int. 2025 Mar 27;2025:2505812. doi: 10.1155/sci/2505812. eCollection 2025.
2
Hypoxia, but Not Normoxia, Reduces Effects of Resveratrol on Cisplatin Treatment in A2780 Ovarian Cancer Cells: A Challenge for Resveratrol Use in Anticancer Adjuvant Cisplatin Therapy.缺氧而非常氧降低白藜芦醇对顺铂治疗 A2780 卵巢癌细胞的作用:白藜芦醇在顺铂辅助抗癌治疗中的应用挑战。
Int J Mol Sci. 2023 Mar 16;24(6):5715. doi: 10.3390/ijms24065715.
3
Icb-1 expression inhibits growth and fulvestrant response of breast cancer cells and affects survival of breast cancer patients.
ICB-1 表达抑制乳腺癌细胞的生长和氟维司群的反应,并影响乳腺癌患者的生存。
Arch Gynecol Obstet. 2021 Jul;304(1):203-213. doi: 10.1007/s00404-020-05902-x. Epub 2021 Jan 3.
4
Icb-1 gene polymorphism rs1467465 is associated with susceptibility to ovarian cancer.免疫检查点蛋白1基因多态性rs1467465与卵巢癌易感性相关。
J Ovarian Res. 2014 Apr 23;7:42. doi: 10.1186/1757-2215-7-42. eCollection 2014.
5
Splice variants of zinc finger protein 695 mRNA associated to ovarian cancer.锌指蛋白 695 mRNA 的剪接变异与卵巢癌相关。
J Ovarian Res. 2013 Sep 5;6(1):61. doi: 10.1186/1757-2215-6-61.